http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#Head http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#assertion http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#provenance http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#pubinfo http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#assertion http://purl.obolibrary.org/obo/DOID_9970 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9970 http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB00191 http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association http://www.w3.org/2000/01/rdf-schema#label phentermine hydrochloride orally disintegrating tablets are sympathomimetic amine anorectic indicated as a short term adjunct a few weeks in a regimen of weight reduction based on exercise behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 3 kg m 2 2 1 the limited usefulness of agents of this class including phentermine hydrochloride should be measured against possible risk factors inherent in their use 1 phentermine hydrochloride orally disintegrating tablets are indicated as a short term a few weeks adjunct in a regimen of weight reduction based on exercise behavioral modification and caloric restriction in the management of exogenous obesity for patients with an initial body mass index greater than or equal to 3 kg m 2 2 below is a chart of body mass index bmi based on various heights and weights bmi is calculated by taking the patient s weight in kilograms kg divided by the patient s height in meters m squared metric conversions are as follows pounds 2 2 kg inches x 254 meters body mass index bmi kg m 2 header weight 5 5 3 5 6 5 9 6 6 3 14 27 25 23 21 19 18 15 29 27 24 22 2 19 16 31 28 26 24 22 2 17 33 3 28 25 23 21 18 35 32 29 27 25 23 19 37 34 31 28 26 24 2 39 36 32 3 27 25 21 41 37 34 31 29 26 22 43 39 36 33 3 28 23 45 41 37 34 31 29 24 47 43 39 36 33 3 25 49 44 4 37 34 31 the limited usefulness of agents of this class including phentermine hydrochloride see clinical pharmacology 12 1 12 2 http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB00191 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#provenance http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#pubinfo http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig http://purl.org/nanopub/x/hasSignature Z5156CrHSToPkzrjZE9s6SPVigBAAVoqFvgrjYoyFSrHmO2ERENmLherx51WE6yZ64YovWtmZqAm4M7CSZO84/x3zthXvmZVBpU35sCyYWfwLl5InMB1E+iLvoqRRe9il4SKIVmag++A5LjVR0qVwziDHgZnLvKSWq2Hyx/1Zog= http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://purl.org/dc/terms/created 2021-06-27T20:27:35.302+02:00 http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RA17xaV0m-7GTHk_dnmngfT76iNsCGJwtJQ2WJ1L9JBEg https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs